Endologix Acquires Pounce™ Thrombectomy System, Expanding Its Vascular Intervention Portfolio

Endologix’s acquisition of the Pounce Thrombectomy System adds a mechanically differentiated device to its portfolio, targeting DVT and PE. The system’s FDA-cleared status allows immediate market integration and cross-selling to existing IR and vascular surgery clients.